Identification and prioritization of bioaccumulable pharmaceutical substances discharged in hospital effluents.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Environmental Management

• Publication date

  2012-07-30

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.jenvman.2012.03.005PMID 22466706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stockholm Convention on Persistent Organic Pollutants

  2013cited by this paper
• INDUSTRY ISSUES: Pharmaceutical Factories as a Source of Drugs in Water

  2010cited by this paper
• Evaluation of the combined effects of binary mixtures of sodium hypochlorite and surfactants against Daphnia magna Straus

  2009cited by this paper
• Progestagens for human use, exposure and hazard assessment for the aquatic environment.

  2009cited by this paper
• Exposure Assessment of Pharmaceuticals and Their Metabolites in the Aquatic Environment: Application to the French Situation and Preliminary Prioritization

  2008cited by this paper
• Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment.

  2008cited by this paper
• Multi-residue analysis of pharmaceutical compounds in aqueous samples.

  2008cited by this paper
• Fluoxetine effects assessment on the life cycle of aquatic invertebrates.

  2008cited by this paper
• Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.

  2008cited by this paper
• Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities.

  2008cited by this paper
• Human and environmental risk assessment of pharmaceuticals: differences, similarities, lessons from toxicology

  2007cited by this paper
• Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals

  2007cited by this paper
• Study of the combined effects of a peracetic acid-based disinfectant and surfactants contained in hospital effluents on Daphnia magna

  2007cited by this paper
• Tamoxifen effects on the early life stages and reproduction of Japanese medaka (Oryzias latipes).

  2007cited by this paper
• Ketoconazole in the fathead minnow (Pimephales promelas): Reproductive toxicity and biological compensation

  2007cited by this paper
• Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works.

  2007cited by this paper
• In vitro‐in vivo extrapolation of quantitative hepatic biotransformation data for fish. II. Modeled effects on chemical bioaccumulation

  2007cited by this paper
• Ecotoxicology of human pharmaceuticals.

  2006cited by this paper
• Can aquatic distribution of human pharmaceuticals be related to pharmacological data?

  2006cited by this paper
• Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico.

  2006cited by this paper
• The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment.

  2006cited by this paper
• Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.

  2006cited by this paper
• Effects of pharmaceuticals on Daphnia survival, growth, and reproduction.

  2005cited by this paper
• Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment.

  2005cited by this paper
• Removal of pharmaceuticals and fragrances in biological wastewater treatment.

  2005cited by this paper
• Ecotoxicological risk assessment of hospital wastewater: a proposed framework for raw effluents discharging into urban sewer network.

  2005cited by this paper
• Life‐cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1 ng/L reduces egg fertilization success and demasculinizes males

  2005cited by this paper
• Detection of clinically relevant antibiotic-resistance genes in municipal wastewater using real-time PCR (TaqMan).

  2004cited by this paper
• Comparative Assessment of the Inhibition of Recombinant Human CYP19 (Aromatase) by Azoles Used in Agriculture and as Drugs for Humans

  2004cited by this paper
• Increased frequency of drug-resistant bacteria and fecal coliforms in an Indiana Creek adjacent to farmland amended with treated sludge.

  2004cited by this paper
• Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom.

  2004cited by this paper
• Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy.

  2004cited by this paper
• Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia

  2004cited by this paper
• Environmental risk assessment of medicinal products for human use according to European Commission recommendations

  2004cited by this paper
• Assessment of river contamination by estrogenic compounds in Paris area (France).

  2004cited by this paper
• The occurrence of selected human pharmaceutical compounds in UK estuaries.

  2004cited by this paper
• Toxicological effects of disinfections using sodium hypochlorite on aquatic organisms and its contribution to AOX formation in hospital wastewater.

  2004cited by this paper
• Long-Term Exposure to Environmental Concentrations of the Pharmaceutical Ethynylestradiol Causes Reproductive Failure in Fish

  2004cited by this paper
• Fate of natural estrogen conjugates in municipal sewage transport and treatment facilities.

  2003cited by this paper
• Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment.

  2003cited by this paper
• Pharmacodynamic activity of drugs and ecotoxicology--can the two be connected?

  2002cited by this paper
• Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance.

  2002cited by this paper
• Loss of capacity to elevate plasma cortisol in rainbow trout (Oncorhynchus mykiss) treated with a single injection of o,p′‐dichlorodiphenyldichloroethane

  2002cited by this paper
• Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.

  2002cited by this paper
• Environmental risk assessment of pharmaceutical drug substances--conceptual considerations.

  2002cited by this paper
• Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data.

  2002cited by this paper
• Selection and Prioritisation Procedure of Hazardous Substances for the Marine Environment within OSPAR/DYNAMEC

  2002cited by this paper
• Estrogenic potency of chemicals detected in sewage treatment plant effluents as determined by in vivo assays with Japanese medaka (Oryzias latipes)

  2001cited by this paper
• Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use.

  2000cited by this paper
• Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil.

  1999cited by this paper
• Pharmaceuticals and personal care products in the environment: agents of subtle change?

  1999cited by this paper
• Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus

  1998cited by this paper
• Zebra Mussel Spawning Is Induced in Low Concentrations of Putative Serotonin Reuptake Inhibitors.

  1998cited by this paper
• Occurrence, fate and effects of pharmaceutical substances in the environment--a review.

  1998cited by this paper
• Ritonavir

  1998cited by this paper
• Induction and potentiation of parturition in fingernail clams (Sphaerium striatinum) by selective serotonin re-uptake inhibitors (SSRIs).

  1998cited by this paper
• Interference of o,p'DDD with interrenal function and cortisol metabolism in Sarotherodon aureus (Steindachner)

  1983cited by this paper

• Antibióticos

  2025cites this paper
• Screening, prioritization, and identification of key toxic substances in hospital wastewater.

  2025cites this paper
• The Persistence of Refractory Pharmaceuticals in Aquatic Systems and Their Environmental Impacts

  2025cites this paper
• Effective adsorption performance of hemp root-derived activated carbon for tamoxifen-contaminated wastewater

  2025cites this paper
• Removal of cytotoxic tamoxifen from aqueous solutions using a geopolymer-based nepheline–cordierite adsorbent

  2025cites this paper
• Ecosystem risk-based prioritization of micropollutants in wastewater treatment plant effluents across China.

  2024cites this paper
• Adsorptive removal of anticarcinogen pazopanib from aqueous solutions using activated carbon: isotherm, kinetic and thermodynamic studies

  2024cites this paper
• Effect driven prioritization of contaminants in wastewater treatment plants across China: A data mining-based toxicity screening approach.

  2024cites this paper
• Progress and perspectives on cost-effective and eco-friendly mineral functional materials for efficient capture of fluoride and phosphorus

  2024cites this paper
• Development of Analytical Technique for Extraction of Commonly used Antibiotics in River Yamuna Based on liquid-liquid extraction

  2023cites this paper
• Pharmaceutical residues in the ecosystem: Antibiotic resistance, health impacts, and removal techniques.

  2023cites this paper
• Advanced oxidation process of valsartan by activated peroxymonosulfate: Chemical characterization and ecotoxicological effects of its byproducts.

  2023cites this paper
• Anticancer drugs in wastewater and natural environments: A review on their occurrence, environmental persistence, treatment, and ecological risks.

  2023cites this paper
• Octocrylene: From Sunscreens to the Degradation Pathway during Chlorination Processes: Formation of Byproducts and Their Ecotoxicity Assessment

  2022cites this paper
• Cyclophosphamide alters the behaviors of adult Zebrafish via neurotransmitters and gut microbiota.

  2022cites this paper
• ASSESSMENT OF CONVENTIONAL WASTEWATER TREATMENT PLANTS IN REMOVING PHARMACEUTICAL COMPOUNDS: A CASE STUDY OF AL AIN CITY, UAE

  2022influential citation
• Acetaminophen removal by calcium alginate/activated hydrochar composite beads: Batch and fixed-bed studies.

  2022cites this paper
• Secondary Effects of Hypochlorite Treatment on the Emerging Pollutant Candesartan: The Formation of Degradation Byproducts and Their Toxicological Profiles

  2021cites this paper
• Emerging pharmaceuticals and industrial chemicals in Nakdong River, Korea: Identification, quantitative monitoring, and prioritization.

  2021cites this paper
• PEACH PIT CHEMICALLY TREATED BIOMASS AS A BIOSORBENT FOR METFORMIN HYDROCHLORIDE REMOVAL: MODELING AND SORPTION MECHANISMS

  2021cites this paper
• Assessment and Removal of Suspended Solids in Hospital Wastewater Using Clay in Sri Lanka

  2021cites this paper
• Pathways and LegislationTowards Hospital Wastewater Discharged Around Globe

  2021cites this paper
• Environmental risk assessments of multiclass pharmaceutical active compounds: selection of high priority concern pharmaceuticals using entropy-utility functions

  2021cites this paper
• Anticancer drugs in the aquatic ecosystem: Environmental occurrence, ecotoxicological effect and risk assessment.

  2021cites this paper
• LC and NMR Studies for Identification and Characterization of Degradation Byproducts of Olmesartan Acid, Elucidation of Their Degradation Pathway and Ecotoxicity Assessment

  2021cites this paper
• Trattamenti avanzati delle acque reflue per la rimozione di contaminanti emergenti

  2020cites this paper
• Analytical Detection of Pesticides, Pollutants, and Pharmaceutical Waste in the Environment

  2020cites this paper
• Amoxicillin in Water: Insights into Relative Reactivity, Byproduct Formation, and Toxicological Interactions during Chlorination

  2020cites this paper
• Effectiveness of conventional wastewater treatment processes in removing pharmaceutically active compounds

  2020cites this paper
• Fate and Effects of Anticancer Drugs in the Environment

  2020cites this paper
• Evaluación de las concentraciones de acetaminofén presentes en la Planta de Tratamiento de Aguas Residuales de la Universidad Pontificia Bolivariana-Seccional Bucaramanga y su efecto tòxico sobre el Allium Cepa

  2020cites this paper
• Tamoxifen: Occurrence, Fate, Transformation Products, and Non-Conventional Treatment Technologies

  2020cites this paper
• Wheat and ryegrass biomass ashes as effective sorbents for metallic and organic pollutants from contaminated water in lab-engineered cartridge filtration system.

  2020cites this paper
• Enantiomer stability and combined toxicity of duloxetine and econazole on Daphnia magna using real concentrations determined by capillary electrophoresis.

  2019cites this paper
• Synthesis and Characterization of Halloysite/Carbon Nanocomposites for Enhanced NSAIDs Adsorption from Water

  2019cites this paper
• Ranking and prioritizing pharmaceuticals in the aquatic environment of China.

  2019cites this paper
• A scientometric review of biochar research in the past 20 years (1998–2018)

  2019cites this paper
• 2,4-dichlorophenoxyacetic acid (2,4-D) micropollutant herbicide removing from water using granular and powdered activated carbons: a comparison applied for water treatment and health safety

  2019cites this paper
• Ecotoxicological risk assessment of micropollutants from treated urban wastewater effluents for watercourses at a territorial scale: Application and comparison of two approaches.

  2019cites this paper
• Removal of emerging contaminants from the environment by adsorption.

  2018cites this paper
• A case study to identify priority cytostatic contaminants in hospital effluents.

  2018cites this paper
• Application of prioritization approaches to optimize environmental monitoring and testing of pharmaceuticals

  2018cites this paper
• IDENTIFICATION OF PRIORITY PHARMACEUTICAL RESIDUES IN HOSPITAL EFFLUENTS

  2018influential citation
• Determination of pharmaceutical compounds in hospital wastewater and their elimination by advanced oxidation processes

  2018cites this paper
• Treatment and Disposal of Pharmaceutical Wastewater: Toward the Sustainable Strategy

  2018cites this paper
• Environmental fate and ecotoxicological effects of antiretrovirals: A current global status and future perspectives.

  2018cites this paper
• Clay mineral adsorbents for heavy metal removal from wastewater: a review

  2018cites this paper
• Occurrence and Risks of Contrast Agents, Cytostatics, and Antibiotics in Hospital Effluents

  2017cites this paper
• Ecotoxicity of Hospital Wastewater

  2017cites this paper
• Hospital Wastewaters: Characteristics, Management, Treatment and Environmental Risks

  2017influential citation
• Industry-Specific Water Treatment

  2017cites this paper
• Photocatalytic Treatment Techniques using Titanium Dioxide Nanoparticles for Antibiotic Removal from Water

  2017cites this paper
• Microbiota sampled from a polluted stream in Recife-PE, Brazil and its importance to public health

  2017cites this paper
• Consumption-based approach for pharmaceutical compounds in a large hospital

  2017cites this paper
• Pharmaceutical Dispensing and Wasting In Health Care Facilities, Amounts, Costs and Evaluation of Potential Ecologic Effects

  2017cites this paper
• Pharmaceutical Waste Treatment and Disposal of Concentrated Rejects : A Review

  2017cites this paper
• Prioritization of Active Pharmaceutical Ingredients in Hospital Wastewater

  2017cites this paper
• Elimination study of the chemotherapy drug tamoxifen by different advanced oxidation processes: Transformation products and toxicity assessment.

  2017cites this paper
• Bioindicators of wastewater ecotoxicity.

  2016cites this paper
• Dynamics of active pharmaceutical ingredients loads in a Swiss university hospital wastewaters and prediction of the related environmental risk for the aquatic ecosystems.

  2016cites this paper
• Approaches for predicting effects of unintended environmental exposure to an endocrine active pharmaceutical, tamoxifen

  2016influential citation
• A posteriori assessment of ecotoxicological risks linked to building a hospital.

  2016cites this paper
• Validated multi-drug determination using liquid chromatography with tandem mass spectrometry for the evaluation of a commercial drug disposal product.

  2016cites this paper
• Predicted and measured concentrations of pharmaceuticals in hospital effluents. Examination of the strengths and weaknesses of the two approaches through the analysis of a case study.

  2016cites this paper
• Proposal to optimize ecotoxicological evaluation of wastewater treated by conventional biological and ozonation processes

  2016cites this paper
• Neuropsychiatric pharmaceuticals and illicit drugs in wastewater treatment plants: a review

  2016cites this paper
• Is the step-wise tiered approach for ERA of pharmaceuticals useful for the assessment of cancer therapeutic drugs present in marine environment?

  2016cites this paper
• Pharmaceutical Concentrations and Loads in Hospital Effluents: Is a Predictive Model or Direct Measurement the Most Accurate Approach?

  2016cites this paper
• Analysis of chemotherapy drugs and related compounds in aquatic environment: removal, transformation and risk evaluation in eco-friendly and advanced technologies

  2016cites this paper
• Environmental risk analysis and prioritization of pharmaceuticals in a developing world context.

  2016cites this paper
• Hospital effluents management: Chemical, physical, microbiological risks and legislation in different countries.

  2016cites this paper
• Bioaccumulation and analytics of pharmaceutical residues in the environment: A review.

  2016cites this paper
• Widely used pharmaceuticals present in the environment revealed as in vitro antagonists for human estrogen and androgen receptors.

  2016cites this paper
• Hospital and Municipal Wastewater: Identification of Relevant Pharmaceutical Compounds

  2016cites this paper
• Experimental assessment of the bioconcentration of (15)N-tamoxifen in Pseudokirchneriella subcapitata.

  2015cites this paper
• Respective contributions of diet and medium to the bioaccumulation of pharmaceutical compounds in the first levels of an aquatic trophic web

  2015cites this paper
• Bioconcentration of (15)N-tamoxifen at environmental concentration in liver, gonad and muscle of Danio rerio.

  2015cites this paper
• Tamoxifen ecotoxicity and resulting risks for aquatic ecosystems.

  2015cites this paper
• Prioritization methodology for the monitoring of active pharmaceutical ingredients in hospital effluents.

  2015influential citation
• General Characteristics of Hospital Wastewater from Three Different Hospitals in Sri Lanka

  2015cites this paper
• Identification and Treatment of Critical Contaminants for Managed Aquifer Recharge (MAR) with Reclaimed Water

  2015cites this paper
• Seasonal occurrence and distribution of a group of ECs in the water resources of Granada city metropolitan areas (South of Spain): Pollution of raw drinking water

  2015cites this paper
• Unconventional oil and gas extraction as a novel source of endocrine disrupting chemicals to water and the potential for adverse human and animal health outcomes

  2015cites this paper
• Évaluation des risques écotoxicologiques liés aux effluents hospitaliers et recommandations de gestion

  2015cites this paper
• A GGLUTINATION AND H EMAGLUTINATION : S IMILAR P ROPERTIES ?

  2014cites this paper
• Hospital wastewaters treatment : upgrading water systems plans and impact on purifying biomass

  2014cites this paper
• Pharmaceuticals in hospital wastewater: their ecotoxicity and contribution to the environmental hazard of the effluent.

  2014cites this paper
• Removal of emerging contaminants by simultaneous application of membrane ultrafiltration, activated carbon adsorption, and ultrasound irradiation.

  2014cites this paper
• In vitro tests aiding ecological risk assessment of ciprofloxacin, tamoxifen and cyclophosphamide in range of concentrations released in hospital wastewater and surface water.

  2014cites this paper
• Hospital wastewater treatment by fungal bioreactor: removal efficiency for pharmaceuticals and endocrine disruptor compounds.

  2014cites this paper
• Incidence of anticancer drugs in an aquatic urban system: from hospital effluents through urban wastewater to natural environment.

  2014cites this paper
• Biodegradation of pharmaceuticals by Trametes versicolor

  2014cites this paper
• Occurrence of cytostatic compounds in hospital effluents and wastewaters, determined by liquid chromatography coupled to high-resolution mass spectrometry

  2014cites this paper
• Multi-residue analysis of emerging pollutants in benthic invertebrates by modified micro-quick-easy-cheap-efficient-rugged-safe extraction and nanoliquid chromatography-nanospray-tandem mass spectrometry analysis.

  2014cites this paper
• Identification of priority organic compounds in groundwater recharge of China.

  2014cites this paper
• Dynamic assessment of the floc morphology, bacterial diversity, and integron content of an activated sludge reactor processing hospital effluent.

  2013cites this paper
• Beta-lactamase-producing Enterobacteriaceae in hospital effluents.

  2013cites this paper
• Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.

  2013cites this paper
• Quantitative study of controlled substance bedside wasting, disposal and evaluation of potential ecologic effects.

  2013influential citation
• Mitigação do risco ambiental da descarga de efluentes hospitalares : contribuição para a remoção de fármacos

  2013cites this paper